New Oncological Drugs: Analysis of Survival Gain
Author:
Affiliation:
1. Celgene Italia, Milano - Italy
2. Health Publishing & Services, Milano - Italy
3. Facoltà di Farmacia, Dipartimento di Scienze Farmaceutiche, Università di Firenze, Firenze - Italy
Publisher
Aboutscience Srl
Subject
Health Policy
Link
http://journals.sagepub.com/doi/pdf/10.5301/GRHTA.2014.12359
Reference61 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2. Estimates of the worldwide frequency of sixteen major cancers in 1980
3. Trends in the global funding and activity of cancer research
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-effectiveness analysis of caplacizumab in the new standard of care for immune Thrombotic Thrombocytopenic Purpura in Italy;Global & Regional Health Technology Assessment;2021-04-01
2. Pricing of innovative drugs: correlation between incremental cost and survival gain in four countries;Therapeutic Advances in Medical Oncology;2016-05-16
3. Valutazione Della Politica di Pricing Dei Farmaci Oncologici Innovativi: Correlazione Tra Costi e Sopravvivenza in 15 Paesi Europei;Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish;2016-04-11
4. Il Beneficio dei Farmaci Oncologici: Commento All'Articolo di Ballatori e Colleghi;Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish;2015-09
5. Cost-Effectiveness Evaluation of Oncological Drugs Newly Marketed in Italy;Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish;2014-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3